Trials / Sponsors / Lung Cancer Group Cologne
Lung Cancer Group Cologne
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | FGFR Inhibitor in FGFR Dysregulated Cancer Lung Cancer, NSCLC, Pulmonary Neoplasm | Phase 2 | 2019-03-25 |
| Completed | BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell Lung | Phase 2 | 2017-04-13 |
| Unknown | Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 2 | 2007-10-01 |